HomeAI · summaries
Storia in 5 fonti
Experimental hepatitis B drug might offer ‘functional cure’ for a subset of patients | CNN
A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver virus, what’s called a “functional cure,” researchers reported Thursday.
Confronto fonti
5 prospettive sulla stessa storiaTimeline cronologica
- ·
apnews.com
Experimental hepatitis B drug may offer 'functional cure' for some patients
New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus.
- ·
statnews.com
Experimental hepatitis B treatment was a ‘functional cure’ for nearly 1 in 5, new data show
An experimental GSK drug helped 1 in 5 patients with chronic hepatitis B achieve what's known as a functional cure, vastly outpacing current treatments.
- ·
independent.co.uk
Experimental hepatitis B drug might offer 'functional cure' for a subset of patients
New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus
- ·
economictimes.indiatimes.com
GSK's chronic hepatitis B drug helps one in five achieve functional cure in key studies
GSK's experimental hepatitis B drug, bepirovirsen, showed promising results in late-stage studies, with nearly one in five patients achieving a functional cure after six months of…
- ·
FDA fast-tracks promising hepatitis B drug after ‘remarkable’ trial results
New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus
- ·
cnn.com
Experimental hepatitis B drug might offer ‘functional cure’ for a subset of patients | CNN
A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver virus, what’s called a “functional cure,” researchers…